SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

IRLAB Therapeutics Receives US Patent Allowance for Parkinson’s Candidate IRL1117

IRLAB Therapeutics says its Parkinson’s drug candidate IRL1117 has received a US patent allowance.

Related stories